• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SCYX:US

10.0000 USD 0.3600 3.73%

As of 20:10:00 ET on 11/21/2014.

Snapshot for SCYNEXIS Inc (SCYX)

Open: 9.9400 Day's Range: 9.4495 - 10.1000 Volume: 17,951
Previous Close: 9.6400 52wk Range: 5.1020 - 10.1000 1-Yr Rtn: -

Stock Chart for SCYX

No chart data available.
  • SCYX:US 10.0000
  • 1D
  • 1M
  • 1Y
9.6400
Interactive SCYX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SCYX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -3.3750
Est. PEG Ratio -
Market Cap (M USD) 85.12
Shares Outstanding (M) 8.51
30 Day Average Volume 23,504
Price/Book (mrq) 2.1566
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SCYX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SCYX

SCYNEXIS, Inc. provides pharmaceutical products. The Company discovers, develops, and distributes intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans. SCYNEXIS serves customers in the United States.

Yves J RibeillPresident/CEOCharles F Osborne Jr "Chuck"Chief Financial Officer
Eileen C PruetteSecy/General Counsel
More Company Profile & Key Executives for SCYX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil